|
Market Closed -
Nasdaq
02:00:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.530 USD | -2.55% |
|
+5.52% | -77.16% |
| 11/25/11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 01/25/01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 53.93L 48.3L 44.43L 40.26L 75.25L 51Cr 76.66L 5.3Cr 2.13Cr 27Cr 2.02Cr 1.98Cr 85Cr | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 16.12L 14.44L 13.28L 12.03L 22.49L 15Cr 22.91L 1.58Cr 63.57L 8.05Cr 60.49L 59.21L 25Cr | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -2.55% | ||
| Current month | -77.16% | ||
| Current year | -77.16% |
| 5 years | 1.45 |  | 256.2 |
| 10 years | 1.45 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -93.03L -83.32L -76.64L -69.44L -1.3Cr -88Cr -1.32Cr -9.14Cr -3.67Cr -46Cr -3.49Cr -3.42Cr -146.54Cr | -70.24L -62.91L -57.86L -52.43L -98L -67Cr -99.84L -6.9Cr -2.77Cr -35Cr -2.64Cr -2.58Cr -110.64Cr |
| Net Debt | -73.41L -65.75L -60.48L -54.8L -1.02Cr -70Cr -1.04Cr -7.21Cr -2.9Cr -37Cr -2.76Cr -2.7Cr -115.63Cr | -37.81L -33.86L -31.15L -28.22L -52.76L -36Cr -53.74L -3.71Cr -1.49Cr -19Cr -1.42Cr -1.39Cr -60Cr |
Employees
-
Sector
-
| Date | Price | Change |
|---|---|---|
| 30/26/30 | $1.530 | -2.55% |
| 29/26/29 | $1.570 | -3.38% |
| 28/26/28 | $1.625 | +2.85% |
| 27/26/27 | $1.580 | +5.33% |
| 26/26/26 | $1.500 | +3.45% |
- Stock Market
- Stocks
- GRI Stock
Select your edition
All financial news and data tailored to specific country editions
